Results 31 to 40 of about 10,024,591 (280)

Reducing residual thrombotic risk in patients with peripheral artery disease: impact of the COMPASS trial

Drugs in Context, 2020
Patients with peripheral artery disease (PAD) are at a high risk not only for the classical cardiovascular (CV) outcomes (major adverse cardiovascular events; MACE) but also for vascular limb events (major adverse limb events; MALE).
José Luis Hernández, Francisco S Lozano, Vincent Riambau, Manuel Almendro-Delia, Juan Cosín-Sales, Sergi Bellmunt-Montoya, Javier Garcia-Alegria, Xavier Garcia-Moll, Juan José Gomez-Doblas, José R Gonzalez-Juanatey, Carmen Suarez Fernández   +10 more
doaj   +1 more source

Comparison of rivaroxaban-based dual antithrombotic and antiplatelet therapies for symptomatic patients with lower-extremity peripheral artery disease post-revascularization: a retrospective cohort study

Therapeutic Advances in Chronic Disease, 2023
Background: Patients with symptomatic lower-extremity peripheral artery disease (LE-PAD) are prone to serious cardiovascular and limb events. Few studies have evaluated the effect of rivaroxaban-based dual antithrombotic therapy in high-risk patients ...
Ye Ji, Baoyan Wang, Guangyan Wu, Yepeng Zhang, Qing Wang, Min Zhou   +5 more
doaj   +1 more source

Non‐Hispanic Black and Hispanic Patients Have Worse Outcomes Than White Patients Within Similar Stages of Peripheral Artery Disease

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2022
Background Racial and ethnic disparities in outcomes following lower limb revascularization for peripheral artery disease have been ascribed to disease severity at presentation for surgery.
Corey A. Kalbaugh, Brian Witrick, Laksika Banu Sivaraj, Katharine L. McGinigle, Catherine R. Lesko, Samuel Cykert, William P. Robinson   +6 more
doaj   +1 more source

Statins and Major Adverse Limb Events in Patients with Peripheral Artery Disease: A Systematic Review and Meta-Analysis

, 2020
Statins are guidelines recommended in patients with peripheral artery disease (PAD) for the prevention of cardiovascular (CV) events. Comprehensive meta-data on the impact of statins on major adverse limb events (MALE) in PAD patients are lacking.
Pastori, Daniele, Menichelli, Danilo, Hiatt, William R, Farcomeni, Alessio, Del Sole, Francesco, Milanese, Alberto, Violi, Francesco   +6 more
core   +1 more source

Multiple metabolic comorbidities and their consequences among patients with peripheral arterial disease

PLoS ONE, 2022
Older adults with peripheral arterial disease (PAD) have increased risks of major cardiovascular events and hospitalization. Metabolic comorbidities, such as hypertension, diabetes mellitus, and dyslipidemia, are common risk factors for these unfavorable
Young Shin Park, Gi Wook Ryu, Mona Choi
doaj   +2 more sources

Screen-detected abnormal ankle brachial index: A risk indicator for future cardiovascular morbidity and mortality in patients with manifest cardiovascular disease.

PLoS ONE, 2022
ObjectivesThe ankle brachial index (ABI) can be used to diagnose peripheral arterial disease (PAD). The clinical relevance of the ABI, especially in patients with known clinically manifest cardiovascular disease (CVD), is unknown.
Vivianne L Jagt, Constantijn E V B Hazenberg, Jaap Kapelle, Maarten J Cramer, Frank L J Visseren, Jan Westerink, UCC-SMART Study Group   +6 more
doaj   +2 more sources

Influence of preprocedural glycemic control on clinical outcomes of endovascular therapy in diabetic patients with lower extremity artery disease: an analysis from a Korean multicenter retrospective registry cohort

Cardiovascular Diabetology, 2020
Background The influence of intensive glucose control in diabetic patients on the macrovascular outcomes is controversial. Thus, this study aimed to elucidate the effect of preprocedural hemoglobin A1c (HbA1c) on clinical outcomes after endovascular ...
Jung-Joon Cha, Hyoeun Kim, Young-Guk Ko, Donghoon Choi, Jae-Hwan Lee, Chang-Hwan Yoon, In-Ho Chae, Cheol Woong Yu, Seung Whan Lee, Sang-Rok Lee, Seung Hyuk Choi, Yoon Seok Koh, Pil-Ki Min, K-VIS (Korean Vascular Intervention Society) investigators   +13 more
doaj   +1 more source

Urinary Cystatin C Has Prognostic Value in Peripheral Artery Disease

Biomolecules, 2022
Despite its association with adverse outcomes, peripheral artery disease (PAD) remains undertreated. Cystatin C is elevated in patients with renal disease and may be a marker of cardiovascular disease.
Ben Li, Abdelrahman Zamzam, Muzammil H. Syed, Niousha Jahanpour, Shubha Jain, Rawand Abdin, Mohammad Qadura   +6 more
doaj   +1 more source

Outcomes with aspirin and clopidogrel versus aspirin and rivaroxaban in infrainguinal endovascular revascularization for critical limb ischemia

Indian Journal of Vascular and Endovascular Surgery, 2021
Background: The purpose of the study was to assess the benefits of dual antithrombotic therapy in the management of peripheral arterial disease in Indian population.
B Nishan, Vishal Hudgi, K Siva Krishna, V P Ahsan, Roshan Rodney, K B Sumanth Raj   +5 more
doaj   +1 more source

Sortilin levels correlate with major cardiovascular events of diabetic patients with peripheral artery disease following revascularization: a prospective study

Cardiovascular Diabetology, 2020
Background Peripheral artery disease (PAD) represents one of the most relevant vascular complications of type 2 diabetes mellitus (T2DM). Moreover, T2DM patients suffering from PAD have an increased risk of major adverse cardiovascular events (MACE) and ...
Federico Biscetti, Elisabetta Nardella, Maria Margherita Rando, Andrea Leonardo Cecchini, Nicola Bonadia, Piergiorgio Bruno, Flavia Angelini, Carmine Di Stasi, Andrea Contegiacomo, Angelo Santoliquido, Dario Pitocco, Raffaele Landolfi, Andrea Flex   +12 more
doaj   +1 more source